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An evidence-based self-management
package for urinary incontinence in older
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Abstract
Background: Urinary incontinence (UI) is a distressing condition that limits women’s quality of life and places a
heavy burden on health care services. Behavioural treatments are recommended as a first-line treatment. An
evidence-based self-management package was developed following the Medical Research Council (MRC)
framework for complex interventions. This study aimed to evaluate the feasibility and acceptability of the
intervention.
Methods: A mixed-methods approach was undertaken, namely a randomised controlled feasibility study with
nested qualitative study. Fifty women aged 55 or over living with UI, recruited from community centres were
randomly assigned to either a 3-month course with the package with a support session or a control group to
receive the same package only 3 months later. Principal outcome measures were: self-reported quality of life, UI
severity, self-efficacy and psychological status. Analysis of covariance was undertaken to estimate within- and
between- group changes for all outcomes. Acceptability was explored using individual interviews at follow-up.
Results: Fifty women were randomised (24 to intervention, 26 to control); mean age of 69.7 (±9.1) years and mean
UI frequency 2.2 (±2.2) episodes/day at baseline. Overall, 49 women (98%) completed 3-month follow-up (24 in the
intervention, 25 in the control). A positive trend was detected in the impact of UI on their personal relationships (−
3.89, p = 0.088), symptom severity (− 1.77, p = 0.025), UI symptoms scale (− 1.87, p = 0.031) and anxiety status (−
2.31, p = 0.001), respectively. Changes in quality of life and self-efficacy did not differ significantly between groups.
Majority of women (71%) in the intervention group reported subjective improvement after 3 months. Spearman
correlation coefficient was 0.43 (p < 0.05) between their subjective perception of change and self-efficacy. Women
perceived the package being acceptable and described that the package had the potential to increase their
knowledge and confidence to manage symptoms and improve quality of life.
Conclusions: The study demonstrated that the self-management package is feasible and acceptable for older
women with UI. Further studies are needed with a large sample size in clinical settings to evaluate the effectiveness
of this package.
Trial registration: ISRCTN17194896. Registered on 11th September 2019 (retrospectively registered).
Keywords: Urinary incontinence, Self-management, Feasibility, Randomised controlled trial, Acceptability, Mixed
methods
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Background
Urinary incontinence (UI) is a distressing condition that
limits people’s quality of life and places a burden on
those affected and health and social care services [1, 2].
Prevalence in women is estimated to be around about
40%, with an increase with age [3]. Women living with
UI often experience functional limitations and social em-
barrassment, negatively impacting their mental health
[4]. Although several options are available for treating
and managing UI, behavioural treatments are recom-
mended as a first-line treatment therapies for stress, ur-
gency and mixed UI by international UI guidelines
developed worldwide [5], prior to considering more in-
tensive treatments.
Behavioural treatment programmes focusing on single
elements of behavioural strategies have been extensively
researched, e.g. pelvic floor muscle exercises (PFME) [6].
These programmes are sometimes challenging to deliver
as they need multiple appointments, the involvement of
specialised practitioners, and may lack flexibility to re-
spond to individual needs associated with comorbidities
in older women. Many women therefore choose to dis-
engage with the service. Only a third of women with UI
consult a doctor in European countries such as France,
Germany, Spain and the UK, and 20 to 25% of those ex-
periencing significant clinical symptoms seek care and
less than half of them receive treatment [7]. A multifa-
ceted intervention involving behavioural strategies may
be more effective than a single component for the man-
agement of UI in older women [8, 9].
Self-management for chronic conditions is multidi-
mensional and defined as an intervention designed to
develop individuals’ knowledge, skills or psychological
and social resources and their ability to manage their
health condition and consequences, through education,
training and support [10]. Many self-management inter-
ventions have been developed to support people to cope
with their health conditions and improve quality of life.
Positive outcomes reported include a higher degree of
self-efficacy, reduced physical interference, and im-
proved mental health status at follow-up [11–21]. Al-
though evidence for self-management programmes
incorporating multifaceted behavioural treatments for
use in UI among older women is currently limited, our
systematic review concluded that multifaceted self-
management interventions including PFME, bladder
retraining, or combination behavioural techniques are
beneficial.
Following the Medical Research Council (MRC)
framework for developing and evaluating complex
interventions [22], a self-management package was
co-developed with older women with UI and health
professionals providing treatment and care. The ini-
tial draft of the intervention was informed by
synthesis of data from a systematic review and stake-
holder interviews with women and health profes-
sionals. Both groups preferred an evidence-based
self-management package that had the capacity to
meet women’s individual needs with the flexibility to
modify behaviours in coping with UI without signifi-
cant service provision and/or intensive interaction
with health professionals. The initial draft was
reviewed and discussed in detail with an expert
group which consisted of four women with UI, five
health professionals and two lay members. Consen-
sus was reached on the content and format of this
self-management package for older women with UI
using a normal group technique [23]. However, the




The aim of this study was to evaluate the feasibility, ac-
ceptability, and preliminary outcomes of an evidence-
based self-management package for UI in older women.
Specifically, it was to 1) assess the feasibility of the inter-
vention to evaluate the effectiveness of a self-
management package; 2) assess the variation of the main
outcome measures to inform sample size considerations
for a full randomised controlled trial (RCT); 3) provide
preliminary data on the effect of the intervention; 4)
understand the benefits/limitations and acceptability of
the self-management package compared to no active
treatment.
Design
A mixed-methods approach comprising a two-arm RCT
feasibility study with a nested qualitative study was
undertaken. The qualitative study was conducted to
understand how the intervention might work and ex-
plore facilitators and barriers to acceptance of the inter-
vention [24]. This study presented adheres to
CONSORT guidelines.
Patient and public engagement
A project advisory group comprising three older women
(aged 55 plus) living with UI and one nurse working in a
community continence clinic was set up prior to the
commencement of this study, to ensure this study ad-
dressed issues that were important and relevant to
women. The meeting was led by YF and facilitated by
LMc/EAN every 6 months. Participants were provided
with background information and clinical guidelines for
UI management and consulted for their current experi-
ences and expectations of managing UI. They also
reviewed the findings of the systematic review and inter-
view transcripts. All highlighted the need for evidence-
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based practice that has the ability to engage the wider
population and indicated a willingness to use it for UI
self-management. The group also supported the applica-
tion of ethics approval and development of interview
schedules.
Setting
This is a single-centre, randomised controlled feasibility
study of self-management package versus wait-list con-
trol with 12- week post-intervention follow up. Partici-
pants were recruited using flyers posted in community
centres of a local Forum for older people in West York-
shire, UK. A short presentation was also given by the
project researcher in most centres.
Participants
Women were eligible if they were aged 55 or over, had
self-reported symptom of involuntary leakage of urine
and were able to read and speak English. Individuals
who self-reported their UI were caused by neurological
diseases affecting the brain and spinal cord, or were cog-
nitively impaired were excluded.
A consecutive sampling strategy was applied to recruit
participants in this study. Assuming an attrition rate of
20%, a target of 25 per arm was sufficient to have 20
participants in each arm by the end of the study. This
has been recommended as acceptable for a feasibility
trial assuming at worst a medium effect size (Cohen’s
d = 0.2) for a continuous outcome and 80% power [25].
Randomisation
All participants were recruited prior to randomisation to
the intervention. Eligible women were randomised using
a 1:1 ratio to either the intervention or control group.
The randomisation procedure was performed by a web-
based randomisation service (https://sealedenvelope.
com/). Due to the nature of the intervention, this study
is considered open-label and is not allocation concealed
because the researcher delivering the interventions and
the participants were aware of group allocation at the
time of implementation.
Intervention
The experimental intervention was the self-management
package, co-developed with older women living with UI,
health professionals and lay members. The aim of the
package was to provide information and practical skills
for women to self-manage their UI and other symptoms.
Following elements were included: recognition and
awareness, getting the support you need, understanding
the cause, learning to manage your UI, developing a self-
management plan and how can you find out more. De-
scriptions of self-management techniques such as PFME,
bladder training and lifestyle interventions were also
provided. The researcher acted as a facilitator and deliv-
ered the intervention in person immediately after the
completion of baseline data collection. A self-
management brochure was also distributed. The inter-
vention group could request a single one-hour support
session with the researcher if they had any difficulties in
using the package.
The control group did not receive the self-
management package or the support session. However
they had been given a copy of the same package upon
the completion of their follow-up data collection (at 3
months).
Outcome measures
As this was a feasibility study it was appropriate to ex-
plore a range of outcome measures. Standardised self-
reported measures were used to assess participants’
generic and disease-specific quality of life, UI severity,
self-efficacy and psychological health respectively: the
EuroQol (EQ-5D-5 L) [26], King’s Health Questionnaire
(KHQ) [27], International Consultation on Incontinence
Questionnaire – urinary incontinence short form (ICIQ-
UI SF) [28, 29], Geriatric Self-Efficacy index for urinary
incontinence (GSE-UI) [30], and Hospital Anxiety and
Depression Scale (HADS) [31]. Data were collected at
baseline and three-month follow-up. Patient Global Im-
pression: Improvement (PGI-I) was obtained from the
intervention group only at three-month follow up [32].
These measures have been commonly used in research
and practice for women with UI.
Data analysis
Descriptive analyses were undertaken to establish re-
cruitment, drop-out rates and the distribution of
baseline and follow-up characteristics and outcomes.
For each of the above measures, analysis of covari-
ance (ANCOVA) was conducted adjusting for their
baseline values to take account of outcome imbalance
at baseline and estimate the impact of intervention
compared with control [33, 34]. T-tests and Chi-
square tests were applied to compare two groups at
baseline and follow-up for continuous and categorical
variables, respectively. Intention-to-treat analysis was
performed for this study. Data from all subjects were
included in the analysis as randomised. To test the
appropriateness of the analysis, complete case analysis
was undertaken for each of the above outcome mea-
sures to identify the relative treatment effects using a
linear (for continuous variables) and logistic (for
binary outcomes) mixed model. For all analyses, a
two-tailed p-value less than 0.05 was considered sta-
tistically significant and a p-value between 0.05 and
0.1 was interpreted as indicating a trend [35, 36].
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Nested qualitative study
Women in the intervention group were eligible to
participate in this subsequent qualitative study aim-
ing to understand the acceptability of the package.
They were purposively recruited considering differ-
ent types of UI, number of years living with UI, to
enable wider discussions on the self-management
package and their experience. The concept of data
saturation guided sample size for this qualitative
study [37].
Semi-structured individual interviews using open-
ended questions were undertaken at follow-up. Inter-
views were conducted either face-to-face in the partici-
pants’ homes, in a meeting room at the University, or by
telephone, based on participants’ preferences. Interviews
were digitally recorded with permission and transcribed
verbatim for analysis. Interviews focused on exploring
participants’ experience of managing symptoms guided
by the intervention, facilitators and barriers to the use of
the package, comments on the content and format, feed-
back on outcome measures used and suggestions on dis-
semination strategy.
Data analysis was commenced during the interview
phase and the transcription, and continued during
the analysis of the transcriptions, hence early com-
mencement of analysis facilitated the development of
subsequent interviews [38]. Data were analysed using
thematic analysis [39], involving a six-step proced-
ure: familiarising the data, generating initial codes,
searching for themes, reviewing themes, defining and
naming themes, and producing the report. Although
they were presented as a step-by-step procedure, the
analysis was an iterative and reflexive process to fi-
nalise the themes. To ensure trustworthiness and
rigour of the analysis, we double coded the data as a
validity check and explored alternative interpreta-
tions of the data and through discussion with mem-
bers of the research team. Interview transcripts were
managed and analysed using Nvivo, a qualitative




Overall 50 participants (Mage =69.7, SD = 9.1), were
randomly allocated to either intervention (n = 24,
Mage =69.5, SD = 8.9) or control group (n = 26, Mage
=69.8, SD = 9.5). During the 3 months follow-up, no
one in the intervention group requested the support
session with the researcher. One woman in the con-
trol group dropped out due to admission to the hos-
pital for other health conditions. A total of 49
participants with a mean age 69.6 (SD = 9.1) were
included in the complete case analysis. No significant
differences were found for all demographics and UI
characteristics collected at baseline, indicating that
randomisation was achieved between the intervention
and control groups. The majority were white British
(77.6%), completed secondary and higher education
(91.8%), were retired (71.4%), and had delivered 2 or
more children (71.5%). The number of participants
was similar across different UI types. Please see par-
ticipant’s characteristics in Table 1.
Outcome measures
Medians, interquartile range (IQR), mean, standard deviation
(SD) and p-values of all baseline and follow-up outcomes are
shown in Tables 2 and 3, respectively. There were no differ-
ences shown in general quality of life, UI symptoms scale
and emotional health status at baseline, however groups dif-
fered with regard to KHQ severity measures (34.03 vs 48.67,
p = 0.028) and self-efficacy (84.96 vs 57.76, p < 0.001). At
follow-up, differences were detected in KHQ symptom se-
verity (6.38 vs 9.04, p = 0.006), UI symptoms scale (5.38 vs
7.76, p = 0.022), self-efficacy (89.13 vs 69.08, p = 0.007), and
anxiety (5.13 vs 7.80, p = 0.049) at 3-month follow-up.
The effect of the self-management intervention on out-
come measures between intervention and control groups
were demonstrated in Table 4. The difference captured on
each outcome measure was further shown in Figs. 1, 2, 3,
4, 5, 6, 7, 8 and 9, respectively. Participants’ general quality
of life were improved within both groups after the follow-
up, however no significant difference was identified (see
Figs. 1 and 2). Similarly, no difference was shown in UI
specific quality of life (see Figs. 3 and 4), self-efficacy (see
Fig. 7), or depression status (see Fig. 9) between groups.
However, significant differences were detected in partici-
pants’ KHQ symptom severity (− 1.77, p = 0.025; also see
Fig. 5), ICIQ-UI SF symptoms scale (− 1.87, p = 0.031; also
see Fig. 6), and their anxiety status (− 2.31, p = 0.001; also
see Fig. 8), respectively. A positive trend was also observed
in the participants’ KHQ personal relationships (− 3.89,
p = 0.088; also see Fig. 4).
The relationship between the participants’ per-
ceived improvement and the difference in outcomes
within the intervention group was assessed using
Spearman correlations (Table 5). There was a signifi-
cant correlation shown between PGI-I and GSE-UI
(rs= 0.43, p < 0.05). Mean change in GSE-UI for par-
ticipants who responded “better” on the PGI-I were
significantly higher than those who responded “no
change” or “worse”.
Qualitative findings
Individual interviews were undertaken with 15 par-
ticipants from the intervention group at their homes.
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Table 1 Baseline demographics and characteristics
Variable Overall Intervention group Control group p-
value
n % n % n %
Total 49 24 25
Age (Mean, SD) 69.7 9.1 69.5 8.9 69.6 9.6 0.994
Ethnicity 0.157
White British 38 77.6% 16 66.7% 22 88.0%
Asian Indian 9 18.4% 7 29.2% 2 8.0%
Mixed White and Black African 2 4.1% 1 4.2% 1 4.0%
Education 0.486
Primary 4 8.2% 3 12.5% 1 4.0%
Secondary 16 32.7% 9 37.5% 7 28.0%
Further 14 28.6% 5 20.8% 9 36.0%
Higher 15 30.6% 7 29.2% 8 32.0%
Religion 0.108
No religion 9 18.4% 5 20.8% 4 16.0%
Christian 31 63.3% 12 50.0% 19 76.0%
Hindu 9 18.4% 7 29.2% 2 8.0%
Marital status 0.365
Single 6 12.2% 3 12.5% 3 12.0%
Married 27 55.1% 15 62.5% 12 48.0%
Separated 1 2.0% 0 0.0% 1 4.0%
Divorced 3 6.1% 0 0.0% 3 12.0%
Widowed 12 24.5% 6 25.0% 6 24.0%
Employment 0.573
Full time employed 3 6.1% 1 4.2% 2 8.0%
Part time employed 5 10.2% 3 12.5% 2 8.0%
Self employed 1 2.0% 0 0.0% 1 4.0%
Not in paid employment 2 4.1% 1 4.2% 1 4.0%
Unemployed-looking for work 1 2.0% 0 0.0% 1 4.0%
Retired 35 71.4% 19 79.2% 16 64.0%
Unable to work 2 4.1% 0 0.0% 2 8.0%
Children 0.421
None 11 22.4% 5 20.8% 6 24.0%
1 3 6.1% 1 4.2% 2 8.0%
2 18 36.7% 9 37.5% 9 36.0%
3 11 22.4% 4 16.7% 7 28.0%
UI type 0.672
Stress UI 14 28.6% 8 33.3% 6 24.0%
Urge UI 17 34.7% 7 29.2% 10 40.0%
Mixed UI 18 36.7% 9 37.5% 9 36.0%
Frequency of UI (average per day) 0.070
None 16 32.7% 12 50.0% 4 16.0%
1 8 16.3% 3 12.5% 5 20.0%
2 5 10.2% 1 4.2% 4 16.0%
3 9 18.4% 5 20.8% 4 16.0%
4+ 11 22.4% 3 12.5% 8 32.0%
UI urinary incontinence
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Table 2 Median, interquartile range (IQR), mean, standard deviation (SD) and p-values of outcome measurements at baseline
Variable Dimensions Intervention group Control group p-
value
n % Median IQR Mean SD n % Median IQR Mean SD
EQ-5D-5L Mobility 0.675
No/slight problem 18 75.0% 20 80.0%
Moderate/Severe/extreme problem 6 25.0% 5 20.0%
Selfcare 0.527
No/slight problem 22 91.7% 24 96.0%
Moderate/Severe/extreme problem 2 8.3% 1 4.0%
Usual activities 0.662
No/slight problem 19 79.2% 21 84.0%
Moderate/Severe/extreme problem 5 20.8% 4 16.0%
Pain & discomfort 0.315
No/slight problem 14 58.3% 18 72.0%
Moderate/Severe/extreme problem 10 41.7% 7 28.0%
Anxiety & depression 0.524
No/slight problem 20 83.3% 19 76.0%
Moderate/Severe/extreme problem 4 16.7% 6 24.0%
Index 24 0.90 0.23 0.82 0.17 25 0.83 0.14 0.79 0.19 0.643
VAS 24 77.50 27.50 71.67 18.04 25 70.00 25.00 64.40 25.59 0.258
KHQ Part I
General health perception (0-100) 24 25.00 25.00 33.33 21.70 25 25.00 25.00 32.00 15.34 0.804
Incontinence impact (0-100) 24 33.33 33.33 45.83 23.70 24 66.67 33.33 56.94 20.80 0.091
Part II
Role limitations (0-100) 24 16.67 33.33 20.14 22.51 25 33.33 33.33 33.33 24.06 0.054
Physical limitations (0-100) 24 16.67 41.67 22.92 22.42 25 33.33 33.33 30.67 20.79 0.216
Social limitations (0-100) 24 0.00 13.89 9.03 13.19 25 0.00 22.22 16.44 24.40 0.195
Personal relationships (0-100) 15 0.00 0.00 5.56 12.06 14 0.00 0.00 11.90 25.68 0.396
Emotions (0-100) 24 11.11 22.22 16.67 19.93 24 11.11 11.11 17.59 14.98 0.856
Sleep/energy (0-100) 24 33.33 41.67 37.50 28.34 25 50.00 50.00 47.33 32.16 0.263
Severity measures (0-100) 24 33.33 29.17 34.03 22.10 25 41.67 33.33 48.67 22.91 0.028
Part III
Symptom severity scale (0-30) 24 7.50 5.50 8.00 4.39 25 10.00 3.00 9.92 4.06 0.119
ICIQ-UI SF Scale (0-21) 24 8.00 6.50 8.63 4.03 25 9.00 6.00 9.68 4.19 0.374
GSE-UI Scale (0-120) 24 84.50 33.50 84.96 18.89 25 55.00 23.00 57.76 23.55 0.000
HADS Anxiety scale (0-21) 24 6.50 6.50 7.13 5.12 25 7.00 5.00 7.56 4.56 0.755
Normal 13 54.2% 13 52.0% 0.868
Mild 7 29.2% 6 24.0%
Moderate 2 8.3% 4 16.0%
Severe 2 8.3% 2 8.0%
Depression scale (0-21) 24 3.00 3.50 3.67 3.29 25 3.00 4.00 3.88 4.02 0.840
Normal 20 83.3% 23 92.0% 0.318
Mild 2 8.3% 0 0.0%
Moderate 2 8.3% 1 4.0%
Severe 0 0
T-tests for continuous variables and chi-square tests for categorical variablesVAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International
Consultation on Incontinence Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety
and Depression Scale
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Table 3 Median, interquartile range (IQR), mean, standard deviation (SD) and p-values of outcome measurements at 12-week follow up
Variable Dimensions Intervention group Control group p-
value
n % Median IQR Mean SD n % Median IQR Mean SD
EQ-5D-5L Mobility 0.478
No/slight problem 21 87.5% 20 80.0%
Moderate/Severe/extreme problem 3 12.5% 5 20.0%
Selfcare 0.322
No/slight problem 24 100.0% 24 96.0%
Moderate/Severe/extreme problem 0 0.0% 1 4.0%
Usual activities 0.950
No/slight problem 20 83.3% 21 84.0%
Moderate/Severe/extreme problem 4 16.7% 4 16.0%
Pain & discomfort 0.682
No/slight problem 17 70.8% 19 76.0%
Moderate/Severe/extreme problem 7 29.2% 6 24.0%
Anxiety & depression 0.957
No/slight problem 21 87.5% 22 88.0%
Moderate/Severe/extreme problem 3 12.5% 3 12.0%
Index 24 0.92 0.26 0.86 0.16 25 0.88 0.16 0.83 0.19 0.471
VAS 24 80.00 20.00 78.54 17.60 25 75.00 15.00 73.00 14.93 0.240
KHQ Part I
General health perception (0-100) 24 25.00 12.50 30.21 23.29 25 25.00 25.00 31.00 20.77 0.900
Incontinence impact (0-100) 24 33.33 33.33 45.83 21.56 25 33.33 33.33 49.33 25.68 0.609
Part II
Role limitations (0-100) 24 16.67 33.33 20.14 23.04 25 33.33 33.33 30.67 23.90 0.123
Physical limitations (0-100) 24 16.67 33.33 22.92 22.42 25 33.33 33.33 32.67 24.76 0.156
Social limitations (0-100) 24 0.00 5.56 5.56 10.87 25 0.00 11.11 8.22 20.98 0.581
Personal relationships (0-100) 16 0.00 0.00 0.00 0.00 16 0.00 0.00 5.21 11.74 0.086
Emotions (0-100) 24 11.11 22.22 12.50 14.40 25 11.11 22.22 16.44 20.06 0.435
Sleep/energy (0-100) 24 16.67 33.33 27.08 31.01 25 33.33 33.33 37.33 31.28 0.255
Severity measures (0-100) 24 25.00 16.67 26.39 17.66 25 33.33 25.00 37.33 20.99 0.055
Part III
Symptom severity scale (0-30) 24 6.00 4.00 6.38 2.93 25 10.00 4.00 9.04 3.51 0.006
ICIQ-UI SF Scale (0-21) 24 4.50 4.00 5.38 2.83 25 9.00 5.00 7.76 4.08 0.022
GSE-UI Scale (0-120) 24 94.50 31.00 89.13 23.86 25 67.00 34.00 69.08 25.46 0.007
HADS Anxiety scale (0-21) 24 5.00 6.00 5.13 4.59 25 7.00 5.00 7.80 4.65 0.049
Normal 19 79.2% 16 64.0% 0.593
Mild 2 8.3% 4 16.0%
Moderate 2 8.3% 2 8.0%
Severe 1 4.2% 3 12.0%
Depression scale (0-21) 24 2.00 3.50 3.08 3.28 25 3.00 3.00 3.44 3.92 0.732
Normal 21 87.5% 22 88.0% 0.720
Mild 2 8.3% 1 4.0%
Moderate 1 4.2% 1 4.0%
Severe 0 0.0% 0
T-tests for continuous variables and chi-square tests for categorical variables VAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International
Consultation on Incontinence Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety
and Depression Scale
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Participants ranged in age from 55 to 86 years. The
majority were retired (11; 73%) and had suffered from
UI for more than 5 years (11; 73%), but had received
no support (13; 87%) from health services.
Each interview lasted between 15 and 48min. A total
of four themes were generated. Facilitators and barriers
to the use of the self-management package followed by
suggestions were also explored under each theme.
Raising awareness and gaining/refreshing knowledge
All participants found that this package had raised
their attention to UI management as well as the
Table 4 Mean, standard error (SE) and p-values of pre-post intervention differences and treatment effect
Variable Dimensions Baseline differencea Follow-up differencea Treatment effectc
ORb/Coef. SE p-value ORb/Coef. SE p-value ORb/Coef. SE p-value
EQ-5D-5L Mobility
No/slight problem






Moderate/Severe/extreme problem 1.38 1.02 0.663 1.05 0.81 0.950 0.74 0.77 0.774
Pain & discomfort
No/slight problem
Moderate/Severe/extreme problem 1.84 1.12 0.317 1.30 0.85 0.683 0.63 0.62 0.637
Anxiety & depression
No/slight problem
Moderate/Severe/extreme problem 0.63 0.46 0.526 1.05 0.91 0.957 1.24 1.14 0.811
Index 0.02 0.05 0.643 0.04 0.05 0.471 0.02 0.03 0.540
VAS 7.27 6.35 0.258 5.54 4.66 0.240 3.82 4.51 0.402
KHQ Part I
General health perception (0-100) 1.33 5.35 0.804 -0.79 6.30 0.900 -1.63 5.38 0.763
Incontinence impact (0-100) -11.11 6.44 0.091 -3.50 6.79 0.609 3.07 6.26 0.626
Part II
Role limitations (0-100) -13.19 6.66 0.054 -10.53 6.71 0.123 -1.06 4.96 0.831
Physical limitations (0-100) -7.75 6.17 0.216 -9.75 6.76 0.156 -3.82 4.96 0.446
Social limitations (0-100) -7.42 5.64 0.195 -2.67 4.80 0.581 1.66 3.61 0.648
Personal relationships (0-100) -6.35 7.37 0.396 -5.21 2.93 0.086 -3.89 2.19 0.088
Emotions (0-100) -0.93 5.09 0.856 -3.94 5.01 0.435 -3.44 3.24 0.294
Sleep/energy (0-100) -9.83 8.67 0.263 -10.25 8.90 0.255 -3.68 6.92 0.598
Severity measures (0-100) -14.64 6.44 0.028 -10.94 5.55 0.055 -1.36 3.86 0.725
Part III
Symptom severity scale (0-30) -1.92 1.21 0.119 -2.67 0.93 0.006 -1.77 0.76 0.025
ICIQ-UI SF Scale (0-21) -1.06 1.18 0.374 -2.39 1.01 0.022 -1.87 0.84 0.031
GSE-UI Scale (0-120) 27.20 6.11 0.000 20.05 7.05 0.007 -4.90 5.16 0.348
HADS Anxiety scale (0-21) -0.44 1.38 0.755 -2.68 1.32 0.049 -2.31 0.66 0.001
Normal
Ill 0.92 0.53 0.879 0.47 0.31 0.245 0.34 0.28 0.188
Depression scale (0-21) -0.21 1.05 0.840 -0.36 1.03 0.732 -0.17 0.46 0.715
Normal
Ill 2.30 2.11 0.364 1.05 0.91 0.957 0.44 0.54 0.505
VAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International Consultation on Incontinence Questionnaire – urinary incontinence short
form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety and Depression ScaleaDifference=intervention-control; bOR: odds ratio;
cFor each outcome, analysis of covariance (ANCOVA) model with the baseline outcome was used to estimate the treatment effect
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resources and support available. Some participants
learned new knowledge and management skills, while
others found it useful to help refresh their memory.
Positive comments were received on the fact that this
package gathered both information and practical skills
in a systematic and structured manner, accompanied
by tips shared by women and health professionals.
“Yeah, I found the information on how to do the pel-
vic floor muscle exercises really good, it describes
exactly what you should do and how much you
should do..” (W5)
A few participants also expressed the need for more de-
tailed information and tips to meet their needs. For in-
stance, information and explanation were desired for
biofeedback, vaginal cones, pads and how certain lifestyles
impacted on UI symptoms and severity. In addition, some
participants shared strategies and experiences of managing
UI, including yoga, weight management programmes, and
using reminders to practice PFME.
Half of the participants also identified the bladder
diary as a potential barrier to the use of this book.
For people who were in employment or regularly in-
volved in outdoor activities, they felt that it was
Fig. 1 Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for EQ-5D
Fig. 2 Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for EQ-5D utility and VAS scores
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Fig. 3 Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for KHQ, Part I
Fig. 4 Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for KHQ, Part II
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difficult and infeasible to measure intake of fluids and
volume voided.
Feeling more confident and motivated to management UI
Participants generally felt more equipped and confident
in managing their UI with resources and support sup-
plied in the package.
“…we can do this, at least we know where to contact,
we can tell the doctors also but if it happens to some-
body you can tell them and they can do this.”(W24)
Participants also expressed their desire to motivate
for self-management, however many of them did not
practice as much as they would like to due to other
commitments. Hence they suggested the inclusion of
information and strategies on how to stay motivated
and develop adherence.
“I suspect a lot of people would read the book, and
think, oh yeah, that’s a really good idea, I ought to
be doing that, and then never, ever actually do
it.”(W46)
Fig. 5 Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for KHQ, Part III
Fig. 6 Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for ICIQ-UI SF
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Being a useful and user-friendly package
All participants preferred the fact that this package was
colour coded, making it easy to read and follow. They
found the texts being easy to read and understand and
the illustrations being appropriate, indicating that there
was no need to book the support session. Some partici-
pants described benefit gained as a result of using this
package.
“The book was very well put together, and very clear,
very easy to read, and it was very informative.” (W6)
“I’m still having the occasional accident, but now
I’m sort of going oh well, I will get there. It’s not a
major setback. But it’s not affecting my life like it
used to.” (W5)
Some of them preferred a smaller size of the package
so they could carry in their handbags, whereas some be-
lieved that people tended to put it away if it was a small
book. A few concerned about the phrase “older women”
used in the title of the package and suggested to remove
it or simply indicate “women over 55”.
Fig. 7 Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for GSE-UI
Fig. 8 Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for HADS, Anxiety
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Exploring dissemination strategies
All participants found the self-reported questionnaires in
the feasibility study acceptable and considered them be-
ing necessary. Some appreciated being involved in this
study. All participants recommended places where ap-
propriate to distribute the package, including doctor’s
surgeries, hospitals, pharmacies, workplaces, public li-
braries, local leisure centres, and other meeting places
for women.
Some participants also expressed the need to design the
package in multiple languages groups who may have limited
access to support and resources. In addition to delivering
the package to individuals, a couple of participants expressed
their preference for a group to enable peer support.
Discussion
This results of this study provide supporting evidence
for the feasibility and acceptability of the self-
management package as a complementary strategy for
the management of UI in older women. This results
of the feasibility RCT have confirmed that recruit-
ment of women with UI from local community cen-
tres who were not actively engaged with health
services is feasible and the drop-out rate is low. Com-
pletion and follow up of the questionnaires were suc-
cessful. The findings of the acceptability study have
suggested that the package may be a useful resource
in improving women’s knowledge and practical skills
for the management of UI. Women also expressed
the need for such intervention for this condition and
commented that questionnaires used to capture infor-
mation were acceptable.
The feasibility RCT showed that women’s UI severity,
symptoms and anxiety status were improved after the
intervention for 3 months. This provides initial evidence
that this self-management package has the capacity to re-
duce both physical and emotional impact of UI on
women. There is an increasing interest in the self-
management of UI consisting in both research and prac-
tice, however many interventions only focused on one
particular skill or technique [6]. The UK Continence Soci-
ety has recommended a support package for patients with
UI as a minimum standard for continence care [41]. With
no evidence-based package being available, this study de-
veloped the intervention consisting of multiple compo-
nents and also demonstrated the acceptability of the
intervention and potential benefit on women’s physical
and psychological health. Therefore, future studies are
needed to evaluate the intervention in other settings in a
larger multicentre trial in order to gain robust evidence.
Although the difference in women’s quality of life or
self-efficacy was not detected, women described that
they felt more confident and motivated to self-manage
their condition and some of them gained improvement
after using the package. Qualitative interviews further
supported these findings and participants reported that
the package was informative and useful in raising their
awareness. A significant correlation was observed
between women’s self-efficacy and their subjective per-
ception of improvement. This suggests that women who
gained a higher level of self-efficacy were likely to ex-
perience an improved subjective perception of their UI
condition. Therefore, individual’s self-efficacy level needs
to be assessed as a way to stratify participants before
randomisation process. For those with extremely low
Fig. 9 Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for HADS, Anxiety
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self-efficacy, interventions with a purpose to build their
confidence may be needed before providing self-
management package.
Existing literature has shown modest benefit of
self-management interventions in older women with
UI. Compared to pharmacological therapies alone,
nonpharmacological interventions, such as behav-
ioural therapy either alone or combined with other
intervention, are more effective in achieving cure or
improvement both stress and urge UI [42]. Clinical
effectiveness of self-management of UI has also been
with respect to symptoms, UI severity, quality of life
and perceptions of improvement when being deliv-
ered in group format with effects maintained (12
months [43]. Similarly, this study has observed im-
provement in symptoms and severity with the self-
management package, and effects on psychological
health. This package appears feasible to modify
women’s quality of life living with UI. Further stud-
ies may be needed to investigate the effectiveness of
self-management interventions on both physical and
psychosocial outcomes in women with UI, at both
short and long term.
Strengths and limitations
The intervention was co-developed with key stakeholders
including women with UI and health professionals. The
feasibility and acceptability of the intervention were evalu-
ated with women who were not actively engaged with
clinical services for UI. Potential positive effects were ob-
served in women’s UI symptoms and their psychological
status, which were further supported by the women’s ex-
periences. However, careful interpretation is needed. The
study was not allocation concealed and the sample size
Table 5 Correlation between PGI-I and changes in outcomes within intervention group
Mean change (SD) PGI-I Spearman's
correlationVery
much worse
Much worse A little
worse






0 (0%) 0 (0%) 4 (16.7) 3 (12.5) 9 (37.5) 7 (29.2) 1 (4.2)
EQ-5D-5L
Index NA NA 0.03 (0.10) 0.08 (0.01) 0.05 (0.09) 0.05 (0.14) 0.00 (.) -0.05
VAS NA NA 2.50 (16.58) 8.33 (23.63) 13.89 (18.33) 2.86 (14.39) -15.00 (.) -0.04
KHQ
Part I
General health perception (0-100) NA NA 12.50 (43.30) 8.33 (14.43) -8.33 (17.68) -14.29 (13.36) 25.00 (.) -0.25
Incontinence impact (0-100) NA NA -8.33 (16.67) 0.00 (33.33) 7.41 (27.78) -4.76 (12.60) 0.00 (.) 0.05
Part II
Role limitations (0-100) NA NA -8.33 (9.62) 5.56 (9.62) -0.00 (18.63) 2.38 (17.82) 0.00 (.) 0.15
Physical limitations (0-100) NA NA 8.33 (28.87) 0.00 (16.67) 1.85 (15.47) -4.76 (8.13) -16.67 (.) -0.19
Social limitations (0-100) NA NA -5.56 (6.42) 0.00 (0.00) -0.62 (14.28) -7.94 (12.36) 0.00 (.) -0.05
Personal relationships (0-100) NA NA -16.67 (16.67) 0.00 (.) 0.00 (0.00) -6.67 (14.91) 0.00 (.) 0.29
Emotions (0-100) NA NA -11.11 (20.29) 0.00 (0.00) -3.70 (9.62) -6.35 (8.74) 22.22 (.) 0.08
Sleep/energy (0-100) NA NA -4.17 (20.97) -22.22 (9.62) -7.41 (23.73) -21.43 (20.89) 50.00 (.) -0.02
Severity measures (0-100) NA NA -12.50 (4.81) -22.22 (17.35) -3.70 (10.30) -4.76 (13.49) 0.00 (.) 0.38*
Part III
Symptom severity scale (0-30) NA NA -1.25 (6.50) 0.00 (4.36) -1.89 (3.92) -2.43 (3.78) 0.00 (.) -0.13
ICIQ-UI SF
Scale (0-21) NA NA -2.75 (2.22) -1.33 (4.51) -3.89 (3.66) -3.86 (4.34) -1.00 (.) -0.02
GSE-UI
Scale (0-120) NA NA -15.00 (17.03) 0.67 (11.02) 8.78 (9.87) 10.71 (15.64) 4.00 (.) 0.43**
HADS
Anxiety scale (0-21) NA NA -1.75 (0.96) -0.67 (1.53) -1.11 (1.96) -4.14 (3.34) 0.00 (.) -0.22
Depression scale (0-21) NA NA -1.00 (1.63) 0.33 (0.58) -0.56 (1.88) -0.86 (2.12) 0.00 (.) -0.02
PGI-I Patient Global Impression: Improvement, VAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International Consultation on Incontinence
Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety and Depression Scale**p <
0.05; *p < 0.1
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was not sufficiently powered to make robust inferences
about the effectiveness of the intervention. Further studies
are needed with a large sample size in multiple clinical set-
tings to evaluate the effectiveness of this package. There is
a possibility of bias associated with the self-reported mea-
sures. Objective information such as pad test or measure
of PFM strength may be needed. It is worth noting that
pad tests are not recommended in the routine assessment
of women with UI by the NICE [44]. Also, women may be
less in favour of the invasiveness of the measures such as
vaginal dynamometer.
Conclusions
The self-management package consisting of multifaceted
behavioural techniques appears feasible to improve UI
symptoms, severity and anxiety status in older women
living with UI. Women also found it useful for increas-
ing their awareness, motivation and knowledge of UI
management. This study suggested that this package has
the potential to be implemented in routine practice with
further evaluation of effectiveness in clinical settings.
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